-
Jefferies: 'We hosted an oversubscribed investor dinner with MANE'
-
Veradermics to present hair loss drug data at dermatology meeting
-
Leerink Partners Starts Veradermics (MANE) at Outperform
-
Citi Starts Veradermics (MANE) at Buy
-
Cantor Fitzgerald Starts Veradermics (MANE) at Overweight
-
Jefferies Starts Veradermics (MANE) at Buy
-
Veradermics halted on volatility
-
Veradermics IPO expected to price at top of $14-$16 range
-
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg

